- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
LI Hepeng, WANG Wei, SUN Jinnan, et al. An analysis of joint patent applications in China’s biopharmaceutical sector from the perspective of industry-academia-research collaboration[J]. J China Pharm Univ, 2024, 55(6): 845 − 854. DOI: 10.11665/j.issn.1000-5048.2024032102
|
This study focuses on joint patent applications in China’s biopharmaceutical industry over the past decade, involving collaborations between industry, academia, and research institutions. The aim was to comprehensively understand the current status of these joint patent applications, identify existing problems, and propose recommendations to the government and relevant agencies on how to address these issues and promote the development of industry-academia-research patent collaborations. The study utilized the incoPat global patent database to obtain the necessary patent data and constructed a dataset of joint patents applied through industry-academia, industry-research, and academia-research collaborations. Statistical analyses were conducted from various perspectives, including types of collaborations, geographical distribution, applicant profiles, and legal status. Based on patent data from Jiangsu province, a collaborative network was constructed for further investigation. The results indicate that joint patent applications in China’s biopharmaceutical industry are in a phase of steady growth, with the majority of joint applications stemming from industry-academia collaboration. However, the joint application for patents between industry and research is relatively slow in development. There is a geographical imbalance in the distribution of patents, with more being concentrated in the east compared to the west. A61P35/00 (anti-tumor drug) is the most active field for industry-academia-research collaborative patent applications, with cooperation encompassing multi-dimensional improvements in the safety, efficacy, and accessibility of drugs. Portions of patents co-filed by industry, academia, and research institutions have failed to transition technology into products, resulting in insufficient practical benefits from the co-filed patents. Chinese research institutions show a lesser engagement in joint patent applications with foreign entities compared to universities and enterprises. Many collaborations in the network are incidental or single, and smaller entities such as small and micro-enterprises and ordinary universities or colleges have not been actively involved in industry-academia-research collaborations. The government and relevant agencies can guide industry-academia-research joint patent applications by streamlining incentive policies, facilitating patent information channels, and promoting cross-regional collaborations.
| [1] |
He YB. The theoretical model of industry-university-research collaboration innovation[J]. Sci Res Manag(科学学研究), 2012, 30(2): 165-174. doi: 10.16192/j.cnki.1003-2053.2012.02.002
|
| [2] |
Chen F, Wu C, Yang W. A new approach for the cooperation between academia and industry: an empirical analysis of the triple helix in East China[J]. Sci Technol Soc, 2016, 21(2): 181-204. doi: 10.1177/0971721816640617
|
| [3] |
Liu YL. The construction path of university innovation system in the new era — Interpretation based on "China's Education Modernization 2035" [J]. China Univ Sci Technol(中国高校科技) , 2019(12): 45-48.
|
| [4] |
Narin F. Patents as indicators for the evaluation of industrial research output[J]. Scientometrics, 1995, 34(3): 489-496.
|
| [5] |
Wang W, Ding ZQ. Reflections on the construction of pharmaceutical and traditional Chinese medicine disciplines based on patent information analysis: taking "Double First-Class" universities as an example[J]. J China Pharm Univ(中国药科大学学报), 2023, 54(6): 769-776.
|
| [6] |
Zhu W, Bai D. Analysis on the current situation of patent cooperation between school and enterprise[C]//2019 International Conference on Economic Management and Model Engineering(ICEMME). IEEE, 2019: 8-11.
|
| [7] |
Li WJ, Chen JL. Research on the supply of industry-university-research cooperation innovation by local colleges and universities — A case study of Guangdong[J]. Decis Inf(决策与信息), 2016(10): 143-147.
|
| [8] |
Hui X, Su-sheng W, Zhi-chao L. Research on Shenzhen university-industry cooperation based on patent data analysis[C]//2010 International Conference on Management Science & Engineering 17th Annual Conference Proceedings. IEEE, 2010: 865-870.
|
| [9] |
Du Y, Wang M, Yin Y. Research on innovation cooperation network of Chinese universities based on patent data[J]. J Eng Technol Manag, 2024, 71: 101784. doi: 10.1016/j.jengtecman.2023.101784
|
| [10] |
Molling G, Hidalgo G, Santini M, et al. Coopetition and innovation in high-tech firms: what we can learn from analysis of the semiconductor industry's patents[J]. World Pat Inf, 2023, 72: 102157. doi: 10.1016/j.wpi.2022.102157
|
| [11] |
Xue Q, Cao YY, Ding T, et al. Research on the patent layout of the biomedical industry[J]. China Inven Pat(中国发明与专利), 2022, 19(1): 19-26,65.
|
| [12] |
Qiu HQ, Yang ZJ, Guo F, et al. Research on the development trend of the future biomedical industry[J]. Chin J Biotechnol (生物工程学报), 2024, 44(01): 8-18. doi: 10.13523/j.cb.2308100
|
| [13] |
Wang CL, Li ZY. The current status and trend of innovation and development of traditional Chinese medicine in China[J]. Chin J New Drugs(中国新药杂志), 2023, 32(20): 2013-2021.
|
| [14] |
You DM, Liu S. Analysis and enlightenment on the evolution of Shenzhen's Industry-University-Research Patent Cooperation Network[J]. Sci Technol Manag Res(科技管理研究), 2022, 42(17): 166-172.
|
| [15] |
Liu XD, Wang BB, Liu PR, et al. Analysis of the current status of effective invention patents of colleges and universities under the background of industry-university-research cooperation: taking Jiangsu Normal University as an example[J]. J Henan Sci Technol(河南科技), 2022, 41(14): 128-133. doi: 10.19968/j.cnki.hnkj.1003-5168.2022.14.027
|
| [16] |
Deng GM, Li JQ, Liu Hong G, et al. Analysis of the research trend of gastrodia elata in China and research on development countermeasures for the future—Taking 20 years of patent data as an example[J]. Agric Technol(农业与技术), 2024, 44(5): 171-177. doi: 10.19754/j.nyyjs.20240315038
|
| [17] |
Diestel R, Schrijver A, Seymour P. Graph theory[J]. Oberwolfach Rep, 2005, 2(1): 135-183. doi: 10.4171/owr/2005/03
|
| [1] | ZHANG Yuting, WANG Anhui, YANG Jinni, LIN Jiachun, TIAN Yuan, DONG Haijuan, ZHANG Zunjian, SONG Rui. Mechanisms of cholesterol metabolism imbalance in a PA-induced non-alcoholic fatty liver disease cell model[J]. Journal of China Pharmaceutical University, 2023, 54(4): 490-500. DOI: 10.11665/j.issn.1000-5048.2023032401 |
| [2] | HUANGFU Yifan, RAN Yuye, FENG Shuo, LI Jing. Comparison of bacterial and human drug metabolizing enzymes in database and prospect of influence of intestinal bacteria on drug metabolism[J]. Journal of China Pharmaceutical University, 2023, 54(1): 122-130. DOI: 10.11665/j.issn.1000-5048.20220705001 |
| [3] | ZHANG Ying, WANG Di, ZHANG Pei, ZHANG Zunjian, XU Fengguo. Metabolomic study on the effects of insulin and oleic acid on the development of colon cancer xenografts[J]. Journal of China Pharmaceutical University, 2021, 52(3): 339-345. DOI: 10.11665/j.issn.1000-5048.20210311 |
| [4] | NIU Qun, SUN Qiushuang, QIU Zhixia, HUANG Fang. Progress of SLC13A5 as a potential pharmacological target of metabolic diseases[J]. Journal of China Pharmaceutical University, 2020, 51(5): 607-613. DOI: 10.11665/j.issn.1000-5048.20200513 |
| [5] | GUO Congying, YANG Songlin, WANG Jun, LIAO Weitao, MO Lingfeng, ZHOU Danshui, NI Weiju, ZENG Yu. Regulation mechanism of Compound Yihe Tea on improving insulin resistance in obesity mice[J]. Journal of China Pharmaceutical University, 2020, 51(1): 68-75. DOI: 10.11665/j.issn.1000-5048.20200111 |
| [6] | LI Yongrong, CHENG Tao, WANG Yongsheng, LI Qin, GAO Bo, HE Yun, BAI Yu. Effect of extract of selenium-enriched Astragalus membranaceus on insulin resistance in streptozotocin-induced diabetic rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 739-745. DOI: 10.11665/j.issn.1000-5048.20180616 |
| [7] | WANG Yiting, ZHAO Mengge, SHENG Xueping, ZHANG Jian, JIANG Cuihua, YIN Zhiqi. Effect of triterpenic acid-enriched fraction from Cyclocarya paliurus on high glucose-induced pancreatic α cells insulin resistance[J]. Journal of China Pharmaceutical University, 2018, 49(2): 215-221. DOI: 10.11665/j.issn.1000-5048.20180212 |
| [8] | ZHANG Xueli, ZHENG Xiao, LIU Yamin, SHAO Hua. Inhibition and mechanism of olanzapine on white adipose tissue beiging in mice[J]. Journal of China Pharmaceutical University, 2015, 46(6): 724-729. DOI: 10.11665/j.issn.1000-5048.20150615 |
| [9] | HE Bi-xia, QIAO Li-yun, PENG Jun, XIE Zhi-ping, DING Qi-long. Effects and mechanisms of mifepristone on insulin-resistant HepG 2 cells[J]. Journal of China Pharmaceutical University, 2011, 42(2): 153-159. |
| [10] | TAN Li-li, SUN Hong-shuang, XIE Sheng-rong, KONG Shu-jia, WANG Yuan, FU Ji-hua. Combination of high fat-hgih sucrose diet and chronic stress promotes insulin resistance in rats[J]. Journal of China Pharmaceutical University, 2009, 40(4): 380-384. |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：312130
DownLoad: